日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

KPNA2 promotes osteosarcoma progression by regulating the alternative splicing of DDX3X mediated by YBX1.

KPNA2 通过调节 YBX1 介导的 DDX3X 的选择性剪接来促进骨肉瘤的进展

Cao Li, Jia Ke, Van Tine B A, Yu Yihan, Peng Yizhong, Chen Xuanzuo, Pan Qing, Yang Wenbo, Zhang Zhicai, Shao Zengwu, Wu Wei

Efficacy and tolerability of trabectedin in elderly patients with sarcoma: subgroup analysis from a phase III, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma

曲贝替定治疗老年肉瘤患者的疗效和耐受性:一项III期随机对照研究的亚组分析,该研究比较了曲贝替定或达卡巴嗪治疗晚期脂肪肉瘤或平滑肌肉瘤患者的疗效。

Jones, R L; Demetri, G D; Schuetze, S M; Milhem, M; Elias, A; Van Tine, B A; Hamm, J; McCarthy, S; Wang, G; Parekh, T; Knoblauch, R; Hensley, M L; Maki, R G; Patel, S; von Mehren, M

Phase II study of MLN8237 (Alisertib) in advanced/metastatic sarcoma

MLN8237(Alisertib)治疗晚期/转移性肉瘤的II期研究

Dickson, M A; Mahoney, M R; Tap, W D; D'Angelo, S P; Keohan, M L; Van Tine, B A; Agulnik, M; Horvath, L E; Nair, J S; Schwartz, G K

Masitinib in advanced gastrointestinal stromal tumor (GIST) after failure of imatinib: a randomized controlled open-label trial

马西替尼治疗伊马替尼失败后的晚期胃肠道间质瘤(GIST):一项随机对照开放标签试验

Adenis, A; Blay, J-Y; Bui-Nguyen, B; Bouché, O; Bertucci, F; Isambert, N; Bompas, E; Chaigneau, L; Domont, J; Ray-Coquard, I; Blésius, A; Van Tine, B A; Bulusu, V R; Dubreuil, P; Mansfield, C D; Acin, Y; Moussy, A; Hermine, O; Le Cesne, A

Cell cycle-regulated phosphorylation of p220(NPAT) by cyclin E/Cdk2 in Cajal bodies promotes histone gene transcription.

细胞周期调节的 p220(NPAT) 在 Cajal 小体中通过细胞周期蛋白 E/Cdk2 磷酸化,促进组蛋白基因转录

Ma T, Van Tine B A, Wei Y, Garrett M D, Nelson D, Adams P D, Wang J, Qin J, Chow L T, Harper J W